Cargando…
Design, Synthesis, and Pharmacology of New Triazole-Containing Quinolinones as CNS Active Agents
Epilepsy and major depressive disorder are the two of the most common central nervous system (CNS) diseases. Clinicians and patients call for new antidepressants, antiseizure medicines, and in particular drugs for depression and epilepsy comorbidities. In this work, a dozen new triazole-quinolinones...
Autores principales: | Zhao, Wennan, Song, Mingxia, Hua, Yi, Zhu, Yangnv, Liu, Wenli, Xia, Qishan, Deng, Xianqing, Huang, Yushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965477/ https://www.ncbi.nlm.nih.gov/pubmed/36838975 http://dx.doi.org/10.3390/molecules28041987 |
Ejemplares similares
-
Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives
por: Song, Mingxia, et al.
Publicado: (2022) -
Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
por: Song, Mingxia, et al.
Publicado: (2023) -
Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H(3) receptor antagonists/inverse agonists containing triazole moiety
por: Song, Mingxia, et al.
Publicado: (2020) -
Synthesis and evaluation of novel chromanone and quinolinone analogues of uniflorol as anti-leishmanial agents
por: Castro, Helena, et al.
Publicado: (2020) -
Design, Synthesis, Molecular Docking, Antiapoptotic and Caspase-3 Inhibition of New 1,2,3-Triazole/Bis-2(1H)-Quinolinone Hybrids
por: El-Sheref, Essmat M., et al.
Publicado: (2020)